Progestational Activity of Certain Steroid-17-Spirolactones

  title={Progestational Activity of Certain Steroid-17-Spirolactones},
  author={Roy Hertz and Wm. W. Tullner},
  journal={Proceedings of the Society for Experimental Biology and Medicine},
  pages={451 - 452}
  • R. HertzW. Tullner
  • Published 1 November 1958
  • Biology, Medicine
  • Proceedings of the Society for Experimental Biology and Medicine
Summary The steroid-17-spirolactones (I and II) have been shown to have progestational activity in the estrogen-primed immature rabbit. 

Tables from this paper

Steroid-induced, steroid-producing, and steroid-responsive tumors.

  • R. Hertz
  • Medicine, Biology
    Current topics in molecular endocrinology
  • 1976
This report will aim to present certain hopefully provocative observations on the nature of steroid-related tumors in man and animals as an introduction to the chapters to follow.


Data from this study are consistent with the menstrual irregularity and amenorrhea seen in women during treatment with spironolactone.

Pharmacology of the endometrium.

  • R. Hertz
  • Biology, Medicine
    Gynecologic oncology
  • 1974


The implications of enzyme induction extend beyond alterations in rates of hepatic microsomal drug oxidation to the amelioration of disease processes such as Gilbert's syndrome and perhaps Cushing’s syndrome.

Effects of some clinically encountered drugs on steroid synthesis and degradation.

Effects of flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat.

The present data show that treatment of intact adult female rats with the pure antiandrogen Flutamide has no effect on the estrous cycle, with no significant change in the plasma concentration of the most important estrogenic compound in the rat, namely, 17 beta-estradiol.

On the fetal masculinizing action of certain oral progestins.

It is suggested that the discordance in androgenic activity exhibited by these compounds in the fetus as compared to the adult may be attributed to differences in the of the end-organs and to delayed fetal disposal of steroid transferred across the placenta.


It is concluded that treatment with spironolactone for 2–4 days will lead to a transient rise in plasma T and urinary DHA, accompanied by increased androgen catabolism and a slightly increased conversion of androgens to oestrogens.

Part VII. The spirolactones

Hyperaldosteronism is present in most conditions which are associated with pathologic accumulations of extracellular fluid, such as nephrosis, Go, 62 congestive cardiac failure,20, sa.

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development

Novel non-steroidal MRAs such as apararenone, esaxerenone and finerenone are in late-stage clinical trials in patients with heart failure, chronic kidney disease, hypertension and liver disease and the history of the various generations of MRAs is reflected.